A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 160
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : F-FDG
Long Form : fluorine-18-fluorodeoxyglucose
No. Year Title Co-occurring Abbreviation
2020 Contributory Role of Positron Emission Tomography in a Left Ventricular Assist Device Recipient at the Time of COVID-19 Pandemic. LVAD, PET
2020 Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: an endearing tool for preoperative risk assessment. COV, CT, PanNENs, PCA, SRD, SZV
2020 Features of IgG4-related lung disease on 18F-FDG PET/computed tomography imaging. CT, GGOs, IgG4-RLD
2020 Improvement of diagnostic accuracy of 18fluorine-fluorodeoxyglucose PET/computed tomography in detection of infective endocarditis using a 72-h low carbs protocol. CT, LCHPHF, LV
2020 In the evaluation of patients with skull base osteomyelitis, does 18F-FDG PET CT have a role? MRI, PET-CT, SBO
2020 PET/computed tomography shows association between subjective pain in knee joints and fluorine-18-fluorodeoxyglucose uptake. CT, NRS, SUV
2020 Positron emission tomography/computed tomography dual imaging using 18-fluorine flurodeoxyglucose and 11C-labeled 2-beta-carbomethoxy-3-beta-(4-fluorophenyl) tropane for the severity assessment of Parkinson disease. C-CFT, DAT, PD, PET/CT
2020 Preoperative 18F-FDG PET/computed tomography predicts survival following resection for colorectal liver metastases. CLM, CSS, CT, DFS, LRFS, MTV, OS, TLG
2020 Prognostic value of neutrophil-to-lymphocyte ratio and its correlation with fluorine-18-fluorodeoxyglucose metabolic parameters in intrahepatic cholangiocarcinoma submitted to 90Y-radioembolization. ICC, NLR
10  2020 Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients. L-SUR, PET/CT, SUR, SUV
11  2019 18F-FDG PET/CT and nestin expression as prognostic tools in pulmonary neuroendocrine tumours. CT
12  2019 18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy. CT, PD, PR, SD
13  2019 18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab. CB, irAEs, PET/CT, PFS
14  2019 18F-FDG PET/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications. AIM, CT, DM
15  2019 Added predictive value of 18F-FDG PET/CT for pediatric rhabdomyosarcoma. EFS, OS, RMS, SUV
16  2019 An enlarged left adrenal gland is an indirect sign of infection on 18F-FDG PET/CT. CT
17  2019 Can 18F-FDG PET/CT diagnose malignant change in benign chondroid tumors? CT
18  2019 Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinoma. cSCC, CT, SUV
19  2019 Combining fluorine-18 fluorodeoxyglucose positron emission tomography and pathological risk factors to predict postoperative recurrence in stage I lung adenocarcinoma. ---
20  2019 Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma. HCC, mCRC, MTV, RECIST
21  2019 Comparison of the volumetric and radiomics findings of 18F-FDG PET/CT images with immunohistochemical prognostic factors in local/locally advanced breast cancer. CT, ER, HER2, PR, SUV
22  2019 Correlation between tumour biology status measured in triple-tracer 18F-fluorodeoxyglucose-18F-fluorothymidine- 18F-fluoromisonidazole-PET/CT study and human papillomavirus status in patients with head and neck cancer. F-FLT, F-FMISO, HPV, HPV, HPV, SUV
23  2019 Diagnostic and prognostic value of 18F-FDG PET/CT imaging in suspected recurrence of male breast cancer. MBC
24  2019 Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMI. CAMONA
25  2019 Fluorine-18-fluorodeoxyglucose positron emission tomography in thyroid nodules with indeterminate cytology: a prospective study. ---
26  2019 Intrahepatic fluorine-18-fluorodeoxyglucose kinetics measured by least squares nonlinear computer modelling and Gjedde-Patlak-Rutland graphical analysis. ---
27  2019 Performing clinical 18F-FDG-PET/MRI of the mediastinum optimising a dedicated, patient-friendly protocol. CT, IQ
28  2019 Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanoma. CR, PD, PR, SUV
29  2019 Pituitary 18F-FDG uptake correlates with serum TSH levels in thyroid cancer patients on 18F-FDG PET/CT. CT, DTC, SUVp, TSH
30  2019 Relationship between regional hepatic glucose metabolism and regional distribution of hepatic fat. CT, ROIs
31  2019 The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer. DFS, PET/CT
32  2019 The role of 18F-FDG PET/CT in soft tissue sarcoma. STS
33  2019 Tissue standardized uptake value is a closer surrogate of blood fluorine-18 fluorodeoxyglucose clearance after division by blood standardized uptake value, illustrated in brain and liver. BGLs, GPR, NT, SUVs
34  2019 Usefulness of respiratory-gated 18F-FDG PET/CT scan protocol in patients having positive myocardial 18F-FDG uptake. CT, SUV
35  2019 Value of fluorine-18-fluorodeoxyglucose PET/CT in localizing the primary lesion in adrenocorticotropic hormone-dependent Cushing syndrome. ACTH, CT, EAS
36  2018 18F-FDG PET/CT in the evaluation of cancer cervix: Where do we stand today? ---
37  2018 18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma. CT, DCE, OS
38  2018 A comparative study of quantitative assessment with fluorine-18-fluorodeoxyglucose positron-emission tomography and endoscopic ultrasound in oesophageal cancer. EUS
39  2018 Benefits of respiratory-gated 18F-FDG PET acquisition in lung disease. CT
40  2018 Clinical and prognostic value of 18F-FDG-PET/CT in restaging of pancreatic cancer. CT, PC, PFS
41  2018 Clinical utility of 18F-FDG PET/CT in low 18F-FDG-avidity breast cancer subtypes: comparison with breast US and MRI. ALN, US
42  2018 Comparison between visual and numerical metrics for the evaluation of patients with Takayasu arteritis with 18F-FDG-PET. AUC, MDS, SUV, TAK
43  2018 Correlations between computed tomography and positron emission tomography/computed tomography findings and pathology in 6 cases of pulmonary epithelioid angiosarcoma. CT, PEA, PET/CT
44  2018 Decrease in total lesion glycolysis and survival after yttrium-90-radioembolization in poorly differentiated hepatocellular carcinoma with portal vein tumour thrombosis. CT, HCC, OS, PVTT, TLG, Y-RE
45  2018 Diagnostic value of 18F-FDG PET/MRI in recurrent pelvis malignancies of female patients: a systematic review and meta-analysis. CI
46  2018 Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors. CT, DECT, MTV, PET, RECIST, SULpeak, TIU, TLG
47  2018 Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies. CT, DOR, ESFTs, PET, SROC
48  2018 Effects of hyperglycemia on fluorine-18-fluorodeoxyglucose biodistribution in a large oncology clinical practice. BGL
49  2018 Evaluation of 18F-FDG PET-CT as a prognostic marker in advanced biliary tract cancer. TLG
50  2018 Evaluation of drug effects on cerebral blood flow and glucose uptake in un-anesthetized and un-stimulated rats: application of free-moving apparatus enabling to keep rats free during PET/SPECT tracer injection and uptake. HMPAO
51  2018 Fluorine-18-fluorodeoxyglucose uptake of bone marrow on PET/CT can predict prognosis in patients with colorectal cancer after curative surgical resection. BM, PET/CT, RFS, SUV
52  2018 Gastrointestinal Stromal Tumor of the Prostate: Staging and Evaluation of Response to Therapy With 18F-FDG PET/CT. CT, EGIST, GIST
53  2018 Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantation. CECT, LT, NCLM
54  2018 Investigating the histopathologic correlates of 18F-FDG PET heterogeneity in non-small-cell lung cancer. MCD, SUV-lacunarity, WSI
55  2018 Lactate dehydrogenase levels and 18F-FDG PET/CT metrics differentiate between mediastinal Hodgkin's lymphoma and primary mediastinal B-cell lymphoma. CI, LDH, PMBCL, SUVpeak
56  2018 Limited additional value of cervical ultrasonography over a negative 18F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with esophageal cancer: a systematic review and meta-analysis. CT
57  2018 Physiologic uptake of 18F-FDG in transposed ovaries may mimic metastasis on 18F-FDG PET/CT imaging. ---
58  2018 Post-therapy lesions in patients with non-Hodgkin's lymphoma characterized by 18F-FDG PET/CT-guided biopsy using automated robotic biopsy arm. NHL, PPV
59  2018 Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in primary hepatic mucosa-associated lymphoid tissue lymphoma: A case report and review of the literature. CT, MALT, PET
60  2018 Prognostic value of pretreatment PET/CT lean body mass-corrected parameters in patients with hepatocellular carcinoma. AST, BCLC, CT, HCC, lbmSUVmax, OS
61  2018 Role of 18F-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer. CT
62  2018 Role of contrast-enhanced 18F-FDG PET/CT imaging in the diagnosis and staging of renal tumors. CE
63  2018 Standardization of image reconstruction parameters for dynamic fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography. FWHM, OSEM, SBRs
64  2018 The feasibility of using 18F-FDG-PET/CT in patients with mucinous breast carcinoma. CT
65  2018 The prognostic and diagnostic value of 18F-FDG PET/CT for assessment of symptomatic osteoarthritis. AC, GH, HR, K/L, OA, SUVs, WOMAC
66  2018 The role of dual time point PET/CT for distinguishing malignant from benign focal 18F-FDG uptake duodenal lesions. AUCs, D-SUVmax, PET/CT, RI, ROC, SUVD, SUVE
67  2018 The value of whole-body contrast-enhanced 18F-FDG PET/CT imaging in the diagnosis and staging of patients with laryngeal carcinoma. ---
68  2018 Tumor heterogeneity, hypoxia, and immune markers in surgically resected non-small-cell lung cancer. DFS, NSCLC
69  2018 Value of 18F-FDG PET/CT imaging in the staging, restaging, monitoring of response to therapy and surveillance of uterine leiomyosarcomas. CT, LMS
70  2017 A new diagnostic marker for differentiating multicentric gliomas from multiple intracranial diffuse large B-cell lymphomas on 18F-FDG PET images. DLBCLs, MRI, PET, ROC, T/N
71  2017 Brown adipose tissue detected by PET/CT imaging is associated with less central obesity. BAT, CT
72  2017 Characterization of viability, scarring and hibernation of the myocardium supplied by epicardial coronary arteries with low flow grades. TIMI
73  2017 Clinical significance of incidental prostatic fluorine-18-fluorodeoxyglucose uptake in the diagnosis of infectious prostatitis in adult males. EPS, IPU
74  2017 Common malignant brain tumors: can 18F-FDG PET/CT aid in differentiation? GBM, SOL
75  2017 Comparative effectiveness: 18F-FDG-PET/CT versus CT for post-treatment follow-up of patients with lung cancer. ---
76  2017 Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients. BC
77  2017 Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions. CT, TLG
78  2017 Diagnostic performance of 18F-FDG PET or PET/CT in restaging renal cell carcinoma: a systematic review and meta-analysis. CI, PET/CT, RCC
79  2017 Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis. CIs, PET/CT
80  2017 Downstream indication to revascularization following hybrid cardiac PET/MRI: preliminary results. AR, CMR, CR, LGE, SPECT
81  2017 Finding the sweet spot for metformin in 18F-FDG-PET. ---
82  2017 Predictive approaches for post-therapy PET/CT in patients with extranodal natural killer/T-cell lymphoma: a retrospective study. ENKTL, IHP, OS, PFS, SUV
83  2017 Pretreatment metabolic parameters measured by 18F-FDG-PET to predict the outcome of first-line chemotherapy in extensive-stage small-cell lung cancer. CT, MTV, SCLC, TLG
84  2017 Prognostic value of preoperative 18F-FDG PET/CT in papillary thyroid cancer patients with a high metastatic lymph node ratio: a multicenter retrospective cohort study. LNs, MLNR
85  2017 Reference values for fluorine-18-fluorodeoxyglucose and fluorine-18-sodium fluoride uptake in human arteries: a prospective evaluation of 89 healthy adults. ---
86  2017 Role of various semiquantitative parameters of 18F-FDG PET/CT studies for interim treatment response evaluation in non-small-cell lung cancer. NSCLC, RECIST, TBR
87  2017 Suite PET/CT neuroimaging for the diagnosis of Parkinson's disease: statistical parametric mapping analysis. C-beta-CFT, C-RAC, CT, DAT, PD, SPM
88  2017 The cardiosplenic axis: another obscure pathophysiological function of the spleen and its investigation using molecular imaging. ---
89  2017 The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma. CT, PCL
90  2017 The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma. PBL
91  2017 The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma. CECT, PFS
92  2017 The role of 68Ga-DOTA-TATE PET/CT scanning in the evaluation of patients with multiple myeloma: preliminary results. CT, Ga-TATE, MM
93  2017 Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review. CT
94  2016 Abdominal Kaposiform Hemangioendothelioma Associated With Lymphangiomatosis Involving Mesentery and Ileum: A Case Report of MRI, CT, and 18F-FDG PET/CT Findings. CT, KH, MRI, PET
95  2016 Appropriate margin thresholds for isocontour metabolic volumetry of fluorine-18 fluorodeoxyglucose PET in sarcoma: a hybrid PET/MRI study. SUV, SUV
96  2016 Assessment of Aggressiveness of Breast Cancer Using Simultaneous 18F-FDG-PET and DCE-MRI: Preliminary Observation. SUV, vp
97  2016 Atherosclerotic 18F-FDG and MDP uptake in femoral arteries, changes with age. BKG
98  2016 Characterization of 'cold' vertebrae on 18F-FDG PET/CT. CT
99  2016 Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients. CT
100  2016 Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results. CT, FNAB, PET, US